摘要:
The effects Of 2 enkephalin analog, (D-Ala2, Met5) and (D-Ala2, D-Leu5) enkephalinamide, on gastrointestinal and colonic motility were investigated in conscious fasted and fed dogs using chronically implanted strain gauges. The drugs, abbreviated here with the names DALAMIDE and DADLE, respectively, were administered by using both the intracerebroventricular [i.c.v.] and i.v. routes at increasing doses. In fasted dogs when administered via the i.c.v. route at a dose of 20 ng .cntdot. kg, DALAMIDE disrupted the migrating myoelectric complex pattern. A similar effect was obtained with a dose 25 times higher (500 ng .cntdot. kg) administered i.v.;at this dosage DALAMIDE administered i.v. also reduced the colonic motility index by 66%. When i.c.v. administered in fed dogs, 2 h after a meal, DALAMIDE (20 ng .cntdot. kg) inhibited gastric motility complex pattern as ectopic complexes for 4-6 h. This effect was not reproduced by i.v. treatment even at the highest dose used (500 ng .cntdot. kg). Both i.c.v. and i.v. administration of DADLE, at doses as high as 100 and 500 ng .cntdot. kg, respectively, affected neither the motility pattern nor the motility index of the antrum and proximal jejunum in the fasted or fed state. I.c.v., but not i.v., administration produced a short (10-15 min) increase of colonic motility. Apparently, Met-enkephalin influences the gastrointestinal motility predominately by a central action, manifested as a migrating myoelectric complex reorganizing effect in fed dogs. Evidently, Leu-enkephalin exerts a predominately centrally mediated stimulation of colonic motility, whereas Met-enkephalin inhibits it probably by a peripheral mechanism.